Healthcare Industry News: ON-Q PainBuster
News Release - September 7, 2006
I-Flow Corporation Announces Group Purchasing Contract with Amerinet(R) for ON-Q(R)
LAKE FOREST, Calif.--(HSMN NewsFeed)--Sept. 7, 2006--I-Flow Corporation (NASDAQ:IFLO ) announced today an agreement with Amerinet® to make the ON-Q® line of post-surgical pain relief devices available to its member facilities. The contract includes the ON-Q PainBuster® Post-Operative Pain Relief System, the ON-Q C-bloc Continuous Nerve Block System and the ON-Q SilverSoaker® Catheter. Patients treated with ON-Q experience significantly better pain relief than with narcotics alone following surgery and need significantly less narcotics during their recovery so they often get back to normal faster after their surgery.Amerinet serves more than 2,100 hospitals and 40,000 non-acute care facilities nationwide.
"We are proud to add Amerinet to our growing list of group purchasing organizations with which we have contracts," said Donald M. Earhart, president and CEO of I-Flow Corporation. "This relationship brings ON-Q to thousands of surgical facilities, thus redefining recovery for more patients by offering superior post-surgical pain relief."
About ON-Q
ON-Q is now labeled to significantly reduce pain better than narcotics and to significantly reduce narcotics intake after surgery. ON-Q is a simple yet elegant device that consists of a small balloon pump that holds a local anesthetic (a pain-numbing medicine) and delivers it automatically through a tiny, specially designed tube (catheter) to provide even distribution of local anesthetic over a wider area, as compared to other catheters, because of its patented wicking capabilities.
Currently, more than 50 studies on the use of ON-Q have been presented and published and more are underway to demonstrate the benefits of ON-Q in additional areas such as reduced infection risk, combination therapies (e.g., a local anesthetic and antibiotic mix, a combination of a local anesthetic and an anti-inflammatory), pediatrics, chronic pain and wound healing. To learn more about the benefits of ON-Q visit www.AskYourSurgeon.com.
About I-Flow
I-Flow Corporation (www.iflo.com) designs, develops and markets technically advanced drug delivery systems that are redefining the standard of care by providing life enhancing, cost-effective solutions for pain relief.
About Amerinet
Amerinet is one of the most innovative and effective health care group purchasing organizations in the United States, partnering with members to improve their operating margins. More than 2,100 hospitals and 40,000 non-acute care facilities create new revenue and reduce expenses with Amerinet's tools for group purchasing, supply chain management, clinical consulting, revenue cycle management, and information and education.
"Safe Harbor" Statement
Certain disclosures made by the Company in this press release and in other reports and statements released by the Company are and will be forward looking in nature, such as comments that express the Company's opinions about trends and factors that may impact future operating results. Disclosures that use words such as the Company "believes," "anticipates," or "expects" or use similar expressions are intended to identify forward-looking statements. Forward-looking statements are subject to certain risks and uncertainties, which could cause actual results to differ from those expected, and readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to republish revised forward-looking statements to reflect the occurrence of unanticipated events. Readers are also urged to carefully review and consider the various disclosures made by the Company in this release, which seek to advise interested parties of the risks, and other factors that affect the Company's business, as well as in the Company's periodic reports on Forms 10-K, 10-Q and 8-K filed with the Securities and Exchange Commission. The risks affecting the Company's business include, among others: implementation of our direct sales strategy; dependence on our suppliers and distributors; reliance on the success of the home health care industry; our continuing compliance with applicable laws and regulations, such as the Food, Drug and Cosmetic Act, and the FDA's concurrence with our management's subjective judgment on compliance issues; the reimbursement system currently in place and future changes to that system; competition in the industry; economic and political conditions in foreign countries; currency exchange rates; inadequacy of booked reserves; technological changes; and product availability and acceptance. All forward-looking statements, whether made in this release or elsewhere, should be considered in context with the various disclosures made by the Company about its business.
Source: I-Flow
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!